logo
The First Thirty Years of the American Journal of Hematology
Morbidity and Mortality in Chronically Transfused Subjects With Thalassemia and Sickle Cell Disease
Adherent Leukocytes Capture Sickle Erythrocytes in an In Vitro Flow Model of Vaso-Occlusion
Platelet GPIIb/IIIa Antagonist, XV459, in Heparin-Induced Thrombocytopenia
Frequency of Intron 1 and 22 Inversions of Factor VIII Gene in Mexican Patients With Severe Hemophilia A
Hypocupremia Associated With Prior Vitamin B12 Deficiency
PTPN22 620W Allele Is Not Associated With Aplastic Anemia
Absence of FTL3 Mutations in Patients With JAK2V617F Mutation Negative Essential Thrombocythemia
Management of Cancer-Associated Thrombotic Microangiopathy
Primary Adrenal Natural Killer/T-Cell Nasal Type Lymphoma
Reversible Posterior Leukoencephalopathy Syndrome After Repeat Intermediate-Dose Cytarabine Chemotherapy in a Patient With Acute Myeloid Leukemia
Concurrent Immune Thrombocytopenic Purpura and Guillain-Barre Syndrome in a Patient With Hashimoto's Thyroiditis
Multiple Myeloma Presented as Acute Interstitial Nephritis and Rheumatoid Arthritis-Like Polyarthritis
Bone Marrow Aplasia—A Rare Complication of Imatinib Therapy in CML Patients
Retrochorionic Hematoma in Congenital Afibrinogenemia
Osseous Metaplasia in Diffuse Large B-Cell Lymphoma of the Kidney
Diffuse Large Cell B Cell Lymphoma Presenting as a Unilateral Eye Mass
Late Onset Membranous Nephropathy Complicating Donor Lymphocyte Infusion for Leukaemia Relapse After Allogeneic Stem Cell Transplantation
Suspected Cardiac Amyloidosis
Timing of Allogeneic BMT for CML Patients in India
A Case of Waldenstrom's Macroglobulinemia Preceeded by Larynx Carcinoma
Quinidine-Induced Lupus Anticoagulant, Hypoprothrombinemia, and Antiprothrombin Antibodies
Glanzmann's Thrombasthenia in Two Pregnant Females
FAS Expression in DLBCL
Differentiation Syndrome With Lethal Lung Injury After Arsenic Trioxide Treatment for Myelodysplastic Syndrome
Chemotherapy and Imatinib-Induced Molecular Remission in Lymphoid Blast Crisis After 20 Years of “Untreated” Chronic Myeloid Leukemia